NCT06711133

Brief Summary

This study will enforce the role of ultrasound in early diagnosis and screening on peripheral neuropathy in comparison with other modalities.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 2, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
Last Updated

February 10, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

November 22, 2024

Last Update Submit

February 7, 2025

Conditions

Peripheral Neuropathy

Outcome Measures

Primary Outcomes (1)

  • The Role of multimodal ultrasonography in evaluation of peripheral neuropathy

    Enforce the role of ultrasound in screening and early detection of nerve affection in peripheral neuropathy in comparison with the traditional modalities as nerve biopsy and nerve conduction

    3 years

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with clinical data of peripheral neuropathy who can cooperate to do the procedure not mentally retarded and healthy skin texture .

You may qualify if:

  • patients with clinical symptoms of peripheral neuropathy

You may not qualify if:

  • patients with unhealthy tissue texture to put on probe

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Telleman JA, Herraets IJ, Goedee HS, van Asseldonk JT, Visser LH. Ultrasound scanning in the diagnosis of peripheral neuropathies. Pract Neurol. 2021 Jun;21(3):186-195. doi: 10.1136/practneurol-2020-002645. Epub 2021 Feb 4.

    PMID: 33541914BACKGROUND

MeSH Terms

Conditions

Peripheral Nervous System Diseases

Condition Hierarchy (Ancestors)

Neuromuscular DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Doctor

Study Record Dates

First Submitted

November 22, 2024

First Posted

December 2, 2024

Study Start

October 1, 2025

Primary Completion

December 15, 2025

Study Completion

January 15, 2026

Last Updated

February 10, 2025

Record last verified: 2025-02